UB Paderborn / Katalog / Suche / in CDI

1 – 20 von 20

Sortiert nach

Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids

Cancer discovery, 2018-02, Vol.8 (2), p.196-215

2018

Link zum Volltext

Verfügbarkeit prüfen

RAS Mutations Are Associated With the Development of Cutaneous Squamous Cell Tumors in Patients Treated With RAF Inhibitors

Journal of clinical oncology, 2012-01, Vol.30 (3), p.316-321

2012

Link zum Volltext

Verfügbarkeit prüfen

A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors

Cancer discovery, 2014-07, Vol.4 (7), p.816-827

2014

Link zum Volltext

Verfügbarkeit prüfen

Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment

PloS one, 2015-10, Vol.10 (10), p.e0140310

2015

Link zum Volltext

Verfügbarkeit prüfen

A phase II study of combined therapy with a BRAF inhibitor (vemurafenib) and interleukin-2 (aldesleukin) in patients with metastatic melanoma

Oncoimmunology, 2018-05, Vol.7 (5), p.e1423172-e1423172

2018

Link zum Volltext

Verfügbarkeit prüfen

NKG2D-Mediated Antitumor Activity by Tumor-Infiltrating Lymphocytes and Antigen-Specific T-Cell Clones Isolated from Melanoma Patients

Clinical cancer research, 2007-12, Vol.13 (24), p.7459-7468

2007

Link zum Volltext

Verfügbarkeit prüfen

Progress in Melanoma Histopathology and Diagnosis

Hematology/oncology clinics of North America, 2009-06, Vol.23 (3), p.467-480

2009

Link zum Volltext

Verfügbarkeit prüfen

Molecular mechanisms of metastasis

Cancer and metastasis reviews, 2006-06, Vol.25 (2), p.203-220

2006

Link zum Volltext

Verfügbarkeit prüfen

EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib

Cancer discovery, 2012-03, Vol.2 (3), p.227-235

2012

Link zum Volltext

Verfügbarkeit prüfen

BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma

Clinical cancer research, 2013-03, Vol.19 (5), p.1225-1231

2013

Link zum Volltext

Verfügbarkeit prüfen

Response to BRAF inhibition in melanoma is enhanced when combined with immune checkpoint blockade

Cancer immunology research, 2014-07, Vol.2 (7), p.643-654

2014

Link zum Volltext

Verfügbarkeit prüfen

Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma

Pigment cell and melanoma research, 2014-01, Vol.27 (1), p.37-47

2014

Link zum Volltext

Verfügbarkeit prüfen

BRAF inhibition is associated with increased clonality in tumor-infiltrating lymphocytes

Oncoimmunology, 2013-10, Vol.2 (10), p.e26615-e26615

2013

Link zum Volltext

Verfügbarkeit prüfen

Extensive Squamous Cell Carcinoma of the Skin Related to Use of Sorafenib for Treatment of FLT3-Mutant Acute Myeloid Leukemia

Journal of clinical oncology, 2016-03, Vol.34 (8), p.e70-e72

2016

Link zum Volltext

Verfügbarkeit prüfen

Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma

Cancer research (Chicago, Ill.), 2003-05, Vol.63 (10), p.2535-2545

2003

Link zum Volltext

Verfügbarkeit prüfen

A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-α in metastatic melanoma patients

Cancer Immunology, Immunotherapy, 2006-08, Vol.55 (8), p.958-968

2006

Link zum Volltext

Verfügbarkeit prüfen

Apoptosis protease activator protein-1 expression is dispensable for response of human melanoma cells to distinct proapoptotic agents

Cancer research (Chicago, Ill.), 2004-10, Vol.64 (20), p.7386-7394

2004

Link zum Volltext

Verfügbarkeit prüfen

Dynamic Gene Expression Analysis Links Melanocyte Growth Arrest with Nevogenesis

Cancer research (Chicago, Ill.), 2009-12, Vol.69 (23), p.9029-9037

2009

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of Metastasis: Seed and Soil

Cancer Metastasis And The Lymphovascular System: Basis For Rational Therapy, 2007, Vol.135, p.119-127

2007

Link zum Volltext

Verfügbarkeit prüfen

1 – 20 von 20

Suche als RSS-Feed

Aktive Filter

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(17)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(20)

Sprache

Englisch
(20)
Japanisch
(4)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids

RAS Mutations Are Associated With the Development of Cutaneous Squamous Cell Tumors in Patients Treated With RAF Inhibitors

A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors

Landscape of Targeted Anti-Cancer Drug Synergies in Melanoma Identifies a Novel BRAF-VEGFR/PDGFR Combination Treatment

A phase II study of combined therapy with a BRAF inhibitor (vemurafenib) and interleukin-2 (aldesleukin) in patients with metastatic melanoma

NKG2D-Mediated Antitumor Activity by Tumor-Infiltrating Lymphocytes and Antigen-Specific T-Cell Clones Isolated from Melanoma Patients

Progress in Melanoma Histopathology and Diagnosis

Molecular mechanisms of metastasis

EGFR-Mediated Reactivation of MAPK Signaling Contributes to Insensitivity of BRAF -Mutant Colorectal Cancers to RAF Inhibition with Vemurafenib

BRAF Inhibition Is Associated with Enhanced Melanoma Antigen Expression and a More Favorable Tumor Microenvironment in Patients with Metastatic Melanoma

Response to BRAF inhibition in melanoma is enhanced when combined with immune checkpoint blockade

Sporadic naturally occurring melanoma in dogs as a preclinical model for human melanoma

BRAF inhibition is associated with increased clonality in tumor-infiltrating lymphocytes

Vaccination of Metastatic Melanoma Patients With Autologous Tumor-Derived Heat Shock Protein gp96-Peptide Complexes: Clinical and Immunologic Findings

Extensive Squamous Cell Carcinoma of the Skin Related to Use of Sorafenib for Treatment of FLT3-Mutant Acute Myeloid Leukemia

Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma

A phase II trial of vaccination with autologous, tumor-derived heat-shock protein peptide complexes Gp96, in combination with GM-CSF and interferon-α in metastatic melanoma patients

Apoptosis protease activator protein-1 expression is dispensable for response of human melanoma cells to distinct proapoptotic agents

Dynamic Gene Expression Analysis Links Melanocyte Growth Arrest with Nevogenesis

Mechanisms of Metastasis: Seed and Soil

Aktive Filter

Suchergebnisse filtern